Cargando…
Retraction
Wei, Y, Wei, L, Li, J, et al. SLCO4A1‐AS1 promotes cell growth and induces resistance in lung adenocarcinoma by modulating miR‐4701‐5p/NFE2L1 axis to activate WNT pathway. Cancer Med. 2020;9:7205‐7217. https://doi.org/10.1002/cam4.3270 The above article, published online in Cancer Medicine on 6th Au...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242849/ https://www.ncbi.nlm.nih.gov/pubmed/37097252 http://dx.doi.org/10.1002/cam4.5771 |
| _version_ | 1785054307007070208 |
|---|---|
| collection | PubMed |
| description | Wei, Y, Wei, L, Li, J, et al. SLCO4A1‐AS1 promotes cell growth and induces resistance in lung adenocarcinoma by modulating miR‐4701‐5p/NFE2L1 axis to activate WNT pathway. Cancer Med. 2020;9:7205‐7217. https://doi.org/10.1002/cam4.3270 The above article, published online in Cancer Medicine on 6th August 2020 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the authors, the journal Editor‐in‐Chief, Dr Stephen Tait and John Wiley and Sons Ltd. The retraction has been requested by the Authors as the study design provided for insufficient results to support the argument, invalidating the conclusions of the paper. |
| format | Online Article Text |
| id | pubmed-10242849 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-102428492023-06-07 Retraction Cancer Med Retraction Wei, Y, Wei, L, Li, J, et al. SLCO4A1‐AS1 promotes cell growth and induces resistance in lung adenocarcinoma by modulating miR‐4701‐5p/NFE2L1 axis to activate WNT pathway. Cancer Med. 2020;9:7205‐7217. https://doi.org/10.1002/cam4.3270 The above article, published online in Cancer Medicine on 6th August 2020 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the authors, the journal Editor‐in‐Chief, Dr Stephen Tait and John Wiley and Sons Ltd. The retraction has been requested by the Authors as the study design provided for insufficient results to support the argument, invalidating the conclusions of the paper. John Wiley and Sons Inc. 2023-04-25 /pmc/articles/PMC10242849/ /pubmed/37097252 http://dx.doi.org/10.1002/cam4.5771 Text en © 2023 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Retraction Retraction |
| title | Retraction |
| title_full | Retraction |
| title_fullStr | Retraction |
| title_full_unstemmed | Retraction |
| title_short | Retraction |
| title_sort | retraction |
| topic | Retraction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242849/ https://www.ncbi.nlm.nih.gov/pubmed/37097252 http://dx.doi.org/10.1002/cam4.5771 |